NCT06953622View on ClinicalTrials.gov

Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale

RecruitingOBSERVATIONAL
Enrollment

330

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
MigrainePatent Foramen Ovale
Interventions
DRUG

Conservative treatment

Receive no antipaletet drug treatment and surgery

DRUG

Antipaletet drug

Use of antipaletet drugs.

PROCEDURE

Patent Foramen Ovale Closure

Receive the surgery of Patent Foramen Ovale

Trial Locations (1)

Unknown

RECRUITING

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER